Results 281 to 290 of about 442,994 (306)
Some of the next articles are maybe not open access.

Interleukin-17 and Its Receptor

Journal of Clinical Immunology, 1997
openaire   +2 more sources

Interleukin-17 Receptor A

2016
Slavko Mojsilović   +3 more
openaire   +1 more source

[Interleukin-17 receptor C].

Sheng li ke xue jin zhan [Progress in physiology], 2015
Qing-Hai, You   +2 more
openaire   +1 more source

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Andrea Rubbert-Roth   +2 more
exaly  

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2015
Iain B Mcinnes   +2 more
exaly  

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello   +2 more
exaly  

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Lancet, The, 2013
Antoinette Moran   +2 more
exaly  

132 Oncostatin M induces interleukin-17 receptor a and synergistic responses to interleukin-17 in mouse aortic adventitial fibroblasts

Cytokine, 2008
Matt Scott   +3 more
openaire   +1 more source

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
B G Feagan, Julian Panes, Arthur Kaser
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag   +2 more
exaly  
humans
animals
mice
inflammation
medicine
female
il-17
male
signal transduction
previous   27  28  29  30  31  

Home - About - Disclaimer - Privacy